Confidential draft. The proposed strategic narrative, rendered as our future homepage. The gold tags mark the spinal element each section expresses.
Glytec
Strategic Narrative · Draft 1.0 Talk with us
Spine 01 · The positioning + the category Each gold tag marks the strategic element the section expresses ... react to the element, not the wording.
Clinical Metabolic Intelligence

See the whole patient.

One hospitalized patient. A dozen metabolic signals, moving at once. GlytecOne reads them together, connects the conditions driving your most serious and most expensive failures, and surfaces the decision that needs a clinician now.

More than 20 years FDA-cleared ~65 hospital systems
Watch how it works · one patient, three moves
GLYTECONE · LIVE VIEW · MED-SURGWorking concept
Detect & Monitor. Every metabolic signal on the patient, watched together on one screen ... most holding steady, a few already drifting out of range.
B. PARKERM, 64 · Bed 6-403, Med-Surg · post-op day 2, CABG · T2DM · CKD-3LIVE
in rangedriftingout of rangeglucose (our origin)
Act. The system connects the drifting signals into a single finding, and routes it to the clinician who owns the decision. Every action is assessed, never automated.
Exposure. Left to signal-by-signal care, the deterioration hides in the gaps ... and the hospital absorbs the cost, condition by condition, all year long.
$37.5Min revenue leakage a year, absorbed when the picture comes late
Illustrative, modeled to a 600-bed system. Better outcomes come first ... the financial case follows directly.
Spine 02 · The enemy
The problem we solve

Your sickest patients are watched in pieces.

A single hospitalized patient can have four or five metabolic conditions moving at the same time. Each one is watched by a different system, and escalated to a different specialist. Nothing watches how those conditions feed each other, and no one is accountable for the patient as a whole.

This is signal-by-signal care. Every tool can prove it did its one job, and the most dangerous, most expensive deterioration grows in the gaps between them ... in plain sight.

Today · four systems, four teams, no whole
Cardiac Cardiology watches this Renal Nephrology watches this Glucose The diabetes team watches this Sepsis markers The rapid-response team watches this THE GAP
Spine 03 · The reframe
The game has changed

This is a different purchase than the one you think you made.

The old game

Buy a tool that keeps blood sugar in range.

  • A department safety task
  • A line item the C-suite never sees
  • One number, watched well ... while the patient fails on five others
The new game

Make sure someone sees the whole patient, in time to act.

  • An enterprise decision about outcomes and margin
  • Owned at the top of the house, not inside one department
  • Every metabolic signal, connected, with a clinician deciding
Would you rather own the number, or own the outcome?
Spine 04 · What we believe
Our point of view

Three things we believe about hospital care.

1No one owns the whole patient, and that is where the most serious failures develop. Each point solution watches its own number. The dangerous, expensive events grow in the space between the tools, where no single system is watching and no one is responsible for assembling the full picture.
2The signal that is easiest to see is rarely the one that matters most. Glucose is a lagging indicator for the conditions that drive cost and risk ... it moves as a result of a crisis, after a patient is already deteriorating. A whole-patient view has to be built on the signals that lead, not the ones that follow.
3Better care and reduced revenue leakage are the same move. See a deteriorating patient sooner and you shorten the stay, protect the margin, and give the clinician room to change the outcome. The patient and the financial result move together.
Spine 05 · The solution
One system underneath it all

See the whole patient, and act while there is still time.

GlytecOne assembles the entire metabolic picture in one place, shows how the conditions connect, and gives every clinician the same complete view. A patient who used to be watched in pieces is finally seen as a whole ... and the software recommends, while the clinician decides. Always.

With GlytecOne · one screen, one whole
B. PARKER · THE WHOLE METABOLIC PICTURE Cardiac Renal Glucose Sepsis markers CONNECTED One finding, routed to the right clinician ... in time to act
Spine 06 · The wedge (why us)
Why Glytec

Everything else watches a number.
We watch the patient.

Point tools alert

Each one watches a single number and pages someone when a threshold trips. Nobody owns what happens between the alarms ... and the deterioration lives exactly there.

Platforms hand you a project

Powerful, general, and empty on day one. You bring the clinical model, the build team, and the months. The intelligence is your job.

GlytecOne is the answer you turn on

Purpose-built for the whole metabolic patient, working day one, clinician in the loop on every decision ... and the only one of the three that is FDA-cleared to act on what it sees, dosing insulin safely at the bedside.

Turnkey · clinician-in-the-loop · FDA-cleared dosing
Spine 07 · The stakes
What is at stake

Better outcomes first. The financial case follows.

Start with the patient, because that is what matters. When one system assembles the whole metabolic picture, the finding that matters surfaces while there is still time to act ... and the clinician, not the software, makes the call. That is better care, and it is what a clinical leader evaluates first.

The money follows directly. Hospitals are paid a fixed amount per diagnosis. When the picture comes late, the stay runs longer, the workup grows, and the hospital absorbs the difference. This is not a savings claim ... it is revenue leakage that is already occurring, and across a health system it reaches into the tens of millions a year. Catch the picture earlier and that leakage stays in the building, quarter after quarter.

Spine 08 · The plan
How we start

Three steps from here to the whole house.

1

Size your exposure

We model what unmanaged metabolic deterioration is costing your system today ... your admissions, your case mix, a defensible number your CFO can pressure-test.

2

Prove it on one unit

Go live on a single unit. Count the catches, the routed decisions, and the days of stay ... measured against your own baseline, not a brochure.

3

Scale to the whole house

Roll out system-wide on the platform you already trust for insulin dosing, and grow into the whole-patient roadmap together.

Spine 09 · The credential
Where we come from

We learned the whole patient by getting one problem right.

For more than 20 years, we have been the FDA-cleared leader in insulin dosing, trusted by roughly 65 hospital systems. Dosing insulin safely is not a single-number problem ... it means accounting for everything moving a patient's metabolism at once. We built an engine to do that, and that engine is how we learned to see the whole patient. GlytecOne is the same intelligence, aimed at everything it was already watching.

20+
years of proven outcomes
FDA
cleared for insulin dosing
100+
patents
~65
hospital systems
Spine 10 · The category flag
A new category in the hospital
Clinical Metabolic Intelligence.
Licensed hospital care, the interconnected conditions that travel together, and a system that surfaces what needs attention now ... with the clinician in the loop on every decision. Glycemic management is the FDA-cleared foundation it is built on.
Clinical · licensed, acute, in the hospital Metabolic · the conditions that travel together Intelligence · what needs attention now

The whole patient, on one screen.

Glytec is the largest insulin-dosing company in the United States. The next chapter is the whole patient ... and it is a world bigger than the company you already know.

Talk with us